Parsons (NYSE:PSN) on Thursday was downgraded to Market Perform from a previous investment rating of Outperform by analysts at financial-services firm William Blair. They said the defense ...
William Blair also issued estimates for Ovid Therapeutics’ Q3 2025 earnings at ($0.16) EPS, Q4 2025 earnings at ($0.17) EPS, FY2025 earnings at ($0.61) EPS and FY2026 earnings at ($0.74) EPS ...
Investing.com -- William Blair downgraded Tempus AI Inc (NASDAQ:TEM) to "Market Perform" from "Outperform" given stock's sharp rally rather than any concerns over the company’s fundamentals.
Investment analysts at William Blair issued their Q1 2025 earnings per share (EPS) estimates for Tenaya Therapeutics in a research report issued to clients and investors on Monday, March 10th. William ...